A simple plasma anticoagulant-exchange method to increase the recovery of factor VIII in therapeutic concentrates

Vox Sang. 1990;58(4):264-9. doi: 10.1111/j.1423-0410.1990.tb04997.x.

Abstract

Donor blood, primarily anticoagulated by acid citrate dextrose formula A (ACD-A), was separated by means of the HemaScience Autopheresis C plasmapheresis device. The citrated plasma was collected directly into a solution of heparin and calcium chloride to achieve a final plasma-ionised calcium concentration of approximately 2 mM, and a heparin concentration of 1.0 IU/ml. Heparin at this concentration provided adequate anticoagulation, and did not result in insoluble cryoprecipitates. Three pairs of donor-matched 4-kg plasma pools (anticoagulant-exchanged variant and ACD-A-anticoagulated control) were constructed and subsequently fractionated to an intermediate stage. The mean recovery of factor VIII from 3 anticoagulant-exchanged pools (394 IU/kg) was 23% greater than the mean recovery from the matched control pools (319 IU/kg). This increased recovery was not achieved at the expense of specific activity.

MeSH terms

  • Anticoagulants / pharmacology*
  • Calcium / analysis
  • Citric Acid*
  • Factor VIII / isolation & purification*
  • Factor VIII / metabolism
  • Fibrin Fibrinogen Degradation Products*
  • Fibrinopeptide A / analysis
  • Fibrinopeptide B / analysis
  • Glucose / analogs & derivatives*
  • Glucose / pharmacology
  • Heparin / pharmacology*
  • Humans
  • Peptide Fragments / analysis
  • Plasmapheresis

Substances

  • Anticoagulants
  • Fibrin Fibrinogen Degradation Products
  • Peptide Fragments
  • fibrinogen Bbeta (15-42)
  • acid citrate dextrose
  • Fibrinopeptide A
  • Citric Acid
  • Fibrinopeptide B
  • Factor VIII
  • Heparin
  • Glucose
  • Calcium